A new Penn Nursing initiative explores the impact of federally funded international bioethics training programs. The ...

In the global healthcare environment, scientific credibility and peer-reviewed visibility are key to the acceptance of traditional medical systems.

A 2019 change in funding to prevent fraud has hampered universities' abilities to update equipment and to offer certain ...

Shanghai-based Zhongshan Hospital, affiliated with Fudan University, where many of the Chinese experts leading global liver ...

ASPIRE-BioNEST at UoH and Tulsi Therapeutics announce world’s first successful pre-clinical trial of Stem Cell–Exosome ...

Tulsi Therapeutics achieves groundbreaking success with novel stem cell–exosome therapy for chronic liver failure at ...

CCRAS announces second edition of scientific writing workshop: Our Bureau, New Delhi Monday, July 28, 2025, 09:00 Hrs [IST] The Central Council for Research in Ayurvedic Sciences ...

In a landmark moment for India’s biotechnology sector, Hyderabad-based biotech startup Tulsi Therapeutics, which focused on regenerative medicine using stem cells and exosomes, and ASPIRE-BioNEST, ...

A new Penn Nursing initiative explores the impact of federally funded international bioethics training programs. The collaborative initiative ...

A newly released study from Duke University's Pontzer Lab, housed in the Department of Evolutionary Anthropology in Trinity ...

Tulsi Therapeutics achieves groundbreaking success in animal trial for liver disease treatment, paving way for human trials.

One Six 8 Ventures’ Judyanna Yu explains why capital alone isn’t enough to scale life sciences companies at home.